JAKMIP3
gene geneOn this page
Also known as FLJ37857NECC2KIAA4091bA140A10.5
Summary
JAKMIP3 (Janus kinase and microtubule interacting protein 3, HGNC:23523) is a protein-coding gene on chromosome 10q26.3, encoding Janus kinase and microtubule-interacting protein 3 (Q5VZ66).
Predicted to enable kinase binding activity and microtubule binding activity. Predicted to be located in Golgi apparatus and membrane.
Source: NCBI Gene 282973 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 154 total
- MANE Select transcript:
NM_001323087
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23523 |
| Approved symbol | JAKMIP3 |
| Name | Janus kinase and microtubule interacting protein 3 |
| Location | 10q26.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ37857, NECC2, KIAA4091, bA140A10.5 |
| Ensembl gene | ENSG00000188385 |
| Ensembl biotype | protein_coding |
| OMIM | 611198 |
| Entrez | 282973 |
Gene structure
Transcript identifiers
Ensembl transcripts: 26 — 20 protein_coding, 5 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000298622, ENST00000477275, ENST00000653512, ENST00000653623, ENST00000654224, ENST00000657318, ENST00000657785, ENST00000657994, ENST00000658847, ENST00000659050, ENST00000659220, ENST00000660144, ENST00000661339, ENST00000662086, ENST00000664697, ENST00000665805, ENST00000666210, ENST00000666974, ENST00000667210, ENST00000668452, ENST00000669241, ENST00000669493, ENST00000669891, ENST00000670120, ENST00000670443, ENST00000684848
RefSeq mRNA: 35 — MANE Select: NM_001323087
NM_001105521, NM_001323086, NM_001323087, NM_001323088, NM_001323089, NM_001323090, NM_001392039, NM_001392040, NM_001392041, NM_001392042, NM_001392043, NM_001392044, NM_001392045, NM_001392046, NM_001392047, NM_001392048, NM_001392049, NM_001392050, NM_001392051, NM_001392052, NM_001392053, NM_001392054, NM_001392055, NM_001392056, NM_001392057, NM_001392058, NM_001392059, NM_001392060, NM_001392061, NM_001392062, NM_001392063, NM_001392064, NM_001392065, NM_001392066, NM_001392067
CCDS: CCDS44494, CCDS91378, CCDS91379, CCDS91380, CCDS91381, CCDS91382, CCDS91383, CCDS91384, CCDS91385, CCDS91386
Canonical transcript exons
ENST00000684848 — 24 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001378454 | 132167953 | 132169033 |
| ENSE00001447619 | 132166983 | 132167055 |
| ENSE00001600714 | 132141920 | 132142048 |
| ENSE00001603031 | 132135041 | 132135160 |
| ENSE00001688152 | 132135930 | 132136076 |
| ENSE00001703981 | 132138119 | 132138178 |
| ENSE00001722320 | 132137254 | 132137289 |
| ENSE00001728840 | 132117077 | 132117574 |
| ENSE00001736561 | 132133312 | 132133527 |
| ENSE00001780209 | 132140451 | 132140579 |
| ENSE00001804364 | 132137019 | 132137150 |
| ENSE00003506621 | 132147952 | 132148050 |
| ENSE00003516919 | 132153759 | 132153827 |
| ENSE00003519491 | 132145518 | 132145580 |
| ENSE00003531540 | 132163209 | 132163412 |
| ENSE00003542795 | 132164670 | 132164735 |
| ENSE00003578297 | 132153913 | 132153990 |
| ENSE00003588532 | 132149412 | 132149510 |
| ENSE00003605390 | 132145107 | 132145190 |
| ENSE00003607825 | 132152958 | 132153023 |
| ENSE00003860692 | 132065946 | 132066061 |
| ENSE00003863327 | 132149982 | 132150041 |
| ENSE00003868677 | 132104672 | 132104943 |
| ENSE00003880538 | 132182357 | 132184858 |
Expression profiles
Bgee: expression breadth ubiquitous, 179 present calls, max score 88.36.
FANTOM5 (CAGE): breadth broad, TPM avg 2.0310 / max 271.3708, expressed in 264 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 107698 | 0.8453 | 148 |
| 107699 | 0.5116 | 120 |
| 107692 | 0.2714 | 110 |
| 107694 | 0.1455 | 54 |
| 107693 | 0.1004 | 67 |
| 107697 | 0.0994 | 57 |
| 107695 | 0.0356 | 18 |
| 107696 | 0.0217 | 15 |
Top tissues by expression
255 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| C1 segment of cervical spinal cord | UBERON:0006469 | 88.36 | gold quality |
| spinal cord | UBERON:0002240 | 87.10 | gold quality |
| corpus callosum | UBERON:0002336 | 86.31 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 85.28 | gold quality |
| right frontal lobe | UBERON:0002810 | 85.01 | gold quality |
| postcentral gyrus | UBERON:0002581 | 84.99 | gold quality |
| pituitary gland | UBERON:0000007 | 84.59 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 84.46 | gold quality |
| cerebellar cortex | UBERON:0002129 | 84.37 | gold quality |
| cerebellum | UBERON:0002037 | 83.78 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 83.78 | gold quality |
| adenohypophysis | UBERON:0002196 | 83.77 | gold quality |
| hypothalamus | UBERON:0001898 | 83.52 | gold quality |
| substantia nigra | UBERON:0002038 | 83.48 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 83.45 | gold quality |
| Ammon’s horn | UBERON:0001954 | 83.42 | gold quality |
| parietal lobe | UBERON:0001872 | 82.80 | gold quality |
| midbrain | UBERON:0001891 | 82.48 | gold quality |
| primary visual cortex | UBERON:0002436 | 82.28 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 82.12 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 81.78 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 81.48 | gold quality |
| frontal cortex | UBERON:0001870 | 81.26 | gold quality |
| brain | UBERON:0000955 | 81.05 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 80.96 | gold quality |
| neocortex | UBERON:0001950 | 80.95 | gold quality |
| cerebral cortex | UBERON:0000956 | 80.89 | gold quality |
| amygdala | UBERON:0001876 | 80.86 | gold quality |
| forebrain | UBERON:0001890 | 80.77 | gold quality |
| occipital lobe | UBERON:0002021 | 80.38 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.40 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | jakmip3 | ENSDARG00000100708 |
| mus_musculus | Jakmip3 | ENSMUSG00000056856 |
| rattus_norvegicus | Jakmip3 | ENSRNOG00000027590 |
Paralogs (2): JAKMIP1 (ENSG00000152969), JAKMIP2 (ENSG00000176049)
Protein
Protein identifiers
Janus kinase and microtubule-interacting protein 3 — Q5VZ66 (reviewed: Q5VZ66)
Alternative names: Neuroendocrine long coiled-coil protein 2
All UniProt accessions (14): A0A590UIU4, A0A590UJ09, A0A590UJ61, A0A590UJC8, A0A590UJF4, A0A590UJG1, A0A590UJH1, A0A590UJQ3, A0A590UJS0, A0A590UJT1, A0A590UK11, A0A590UK42, A0A590UK98, Q5VZ66
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Golgi apparatus.
Tissue specificity. Specifically expressed in the CNS and endocrine tissues. Also detected in other tissues including heart, testis and prostate.
Similarity. Belongs to the JAKMIP family.
RefSeq proteins (35): NP_001098991, NP_001310015, NP_001310016, NP_001310017, NP_001310018, NP_001310019, NP_001378968, NP_001378969, NP_001378970, NP_001378971, NP_001378972, NP_001378973, NP_001378974, NP_001378975, NP_001378976, NP_001378977, NP_001378978, NP_001378979, NP_001378980, NP_001378981, NP_001378982, NP_001378983, NP_001378984, NP_001378985, NP_001378986, NP_001378987, NP_001378988, NP_001378989, NP_001378990, NP_001378991, NP_001378992, NP_001378993, NP_001378994, NP_001378995, NP_001378996 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR024836 | JAKMIP | Family |
| IPR031994 | JAKMIP_C | Domain |
Pfam: PF16034
UniProt features (13 total): coiled-coil region 4, compositionally biased region 3, region of interest 2, sequence variant 2, chain 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5VZ66-F1 | 79.62 | 0.35 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 384
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 65 (showing top):
LFA1_Q6, CAGCTG_AP4_Q5, GTGCCTT_MIR506, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, VDR_Q3, TGCCTTA_MIR124A, GOMF_CYTOSKELETAL_PROTEIN_BINDING, GOMF_KINASE_BINDING, GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP, CAGTATT_MIR200B_MIR200C_MIR429, NFE2L2.V2, MIR8485, MIR548AR_3P, MIR506_3P, MIR124_3P
GO Biological Process (0):
GO Molecular Function (2): microtubule binding (GO:0008017), kinase binding (GO:0019900)
GO Cellular Component (2): Golgi apparatus (GO:0005794), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| tubulin binding | 1 |
| enzyme binding | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
438 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| JAKMIP3 | C2orf81 | A6NN90 | 530 |
| JAKMIP3 | CCDC154 | A6NI56 | 507 |
| JAKMIP3 | SMCO3 | A2RU48 | 489 |
| JAKMIP3 | C14orf119 | Q9NWQ9 | 480 |
| JAKMIP3 | STMP1 | E0CX11 | 479 |
| JAKMIP3 | IQCN | Q9H0B3 | 470 |
| JAKMIP3 | PTK2 | Q05397 | 468 |
| JAKMIP3 | LRRC27 | Q9C0I9 | 431 |
| JAKMIP3 | TYK2 | P29597 | 430 |
| JAKMIP3 | GABBR2 | O75899 | 424 |
| JAKMIP3 | PLAC9 | Q5JTB6 | 420 |
| JAKMIP3 | OR1J4 | Q8NGS1 | 418 |
| JAKMIP3 | GOLGA6L7 | A0A1B0GV03 | 417 |
| JAKMIP3 | PPP4R4 | Q6NUP7 | 398 |
| JAKMIP3 | PYROXD1 | Q8WU10 | 397 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RYBP | PIPSL | psi-mi:“MI:0914”(association) | 0.350 |
| RYBP | FAM186A | psi-mi:“MI:0914”(association) | 0.350 |
| RIMS1 | KIF2A | psi-mi:“MI:0914”(association) | 0.350 |
| HCN1 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| EPHA4 | JAKMIP3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NRIP1 | JAKMIP3 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (6): JAKMIP3 (Affinity Capture-RNA), JAKMIP3 (Affinity Capture-MS), JAKMIP3 (Two-hybrid), JAKMIP3 (Cross-Linking-MS (XL-MS)), JAKMIP3 (Cross-Linking-MS (XL-MS)), JAKMIP3 (Affinity Capture-MS)
ESM2 similar proteins: A0A287B8J2, A6QR54, A8IQT2, A8WUP2, C5E2E7, C9ZN16, G5ECG0, O08788, O16844, O48791, O55156, P13496, P28023, P35458, P45970, P54623, Q01397, Q14203, Q17695, Q23529, Q292S8, Q2KN93, Q2KN94, Q2KN95, Q2KN96, Q2KN97, Q2KN98, Q2KN99, Q2KNA0, Q2KNA1, Q3SWS9, Q585H6, Q5B993, Q5DTN8, Q5M775, Q5SXY1, Q5VZ66, Q69YQ0, Q6PCJ1, Q75EN7
Diamond homologs: A6QR54, Q3SWS9, Q5DTN8, Q5VZ66, Q8BVL9, Q96AA8, Q96N16
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
154 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 138 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4429 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:132104939:GCAAG:G | donor_gain | 1.0000 |
| 10:132104940:CAAG:C | donor_loss | 1.0000 |
| 10:132104941:AAG:A | donor_loss | 1.0000 |
| 10:132104942:AGG:A | donor_loss | 1.0000 |
| 10:132104943:GGTG:G | donor_loss | 1.0000 |
| 10:132104944:GTGG:G | donor_loss | 1.0000 |
| 10:132104945:T:G | donor_loss | 1.0000 |
| 10:132117570:GGCTG:G | donor_gain | 1.0000 |
| 10:132117571:GCTG:G | donor_gain | 1.0000 |
| 10:132117571:GCTGG:G | donor_gain | 1.0000 |
| 10:132117572:CTGGT:C | donor_loss | 1.0000 |
| 10:132117573:TGG:T | donor_loss | 1.0000 |
| 10:132117574:GGTA:G | donor_loss | 1.0000 |
| 10:132117575:G:GG | donor_gain | 1.0000 |
| 10:132117575:G:T | donor_loss | 1.0000 |
| 10:132117576:T:A | donor_loss | 1.0000 |
| 10:132133520:G:GT | donor_gain | 1.0000 |
| 10:132133520:G:T | donor_gain | 1.0000 |
| 10:132133523:GCCCT:G | donor_gain | 1.0000 |
| 10:132133528:G:GG | donor_gain | 1.0000 |
| 10:132135036:TTTA:T | acceptor_loss | 1.0000 |
| 10:132135037:TTA:T | acceptor_loss | 1.0000 |
| 10:132135038:TAG:T | acceptor_loss | 1.0000 |
| 10:132135039:A:AC | acceptor_loss | 1.0000 |
| 10:132135039:A:AG | acceptor_gain | 1.0000 |
| 10:132135040:G:GA | acceptor_gain | 1.0000 |
| 10:132135143:G:GT | donor_gain | 1.0000 |
| 10:132135151:GAA:G | donor_gain | 1.0000 |
| 10:132135152:A:T | donor_gain | 1.0000 |
| 10:132135157:GCTG:G | donor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000014807 (10:132094439 C>T), RS1000031580 (10:132085197 C>G), RS1000034852 (10:132179396 T>C), RS1000045541 (10:132100727 G>A), RS1000046577 (10:132115443 T>C,G), RS1000078017 (10:132075215 A>G), RS1000099516 (10:132146289 C>T), RS1000120555 (10:132183286 T>C), RS1000141176 (10:132148661 C>T), RS1000143664 (10:132109494 G>T), RS1000177594 (10:132174099 T>C), RS1000179508 (10:132171395 C>T), RS1000190210 (10:132107286 G>T), RS1000210581 (10:132111528 G>A,C), RS1000216354 (10:132063386 G>T)
Disease associations
OMIM: gene MIM:611198 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001737_28 | Chronic obstructive pulmonary disease-related biomarkers | 4.000000e-06 |
| GCST007158_1 | Refractive astigmatism | 3.000000e-06 |
| GCST010988_456 | Adult body size | 6.000000e-12 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004810 | interleukin-6 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Aflatoxin B1 | affects methylation, decreases expression, decreases methylation | 3 |
| sodium arsenite | decreases methylation, increases expression | 2 |
| Benzo(a)pyrene | decreases methylation, affects methylation | 2 |
| Lead | increases expression, affects expression | 2 |
| bisphenol A | decreases methylation | 1 |
| terbufos | increases methylation | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| abrine | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Amiodarone | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzene | increases expression | 1 |
| Diazinon | increases methylation | 1 |
| Fonofos | increases methylation | 1 |
| Melphalan | decreases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Niclosamide | increases expression | 1 |
| Parathion | increases methylation | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.